Form 4 for INSM INSMED Inc
Accepted 2021-12-28 00:00:00 ET · period of report 2021-12-23 · accession 0001140361-21-043222 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-28 | 2021-12-23+ | INSM | COB, CEO, Dir | S - Sale+OE | $27.97 | -96.6K | 202.2K | -32% | -$2.70M | |
| DM | 2021-12-28 | 2021-12-23+ | INSM | COB, CEO, Dir | M - OptEx | $13.86 | +96.6K | 248.8K | +63% | +$1.34M | |
| DM | 2021-12-28 | 2021-12-23+ | INSM | COB, CEO, Dir | M - OptEx | $0.00 | -96.6K | 76.8K | -56% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-23 | S | D | 3,386 | $28.20 | 202,219 | D | — | — | (F2) This is the weighted average sales price representing 3,386 shares sold at prices ranging from $28.00 to $28.49 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 2 | Common | Common Stock | 2021-12-27 | M | A | 46,614 | $14.24 | 248,833 | D | — | — | |
| 3 | Common | Common Stock | 2021-12-23 | M | A | 3,386 | $3.40 | 205,605 | D | — | — | |
| 4 | Common | Common Stock | 2021-12-27 | S | D | 46,614 | $27.72 | 202,219 | D | — | — | (F4) This is the weighted average sales price representing 46,614 shares sold at prices ranging from $27.43 to $28.15 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 5 | Common | Common Stock | 2021-12-23 | M | A | 46,614 | $14.24 | 248,833 | D | — | — | |
| 6 | Common | Common Stock | 2021-12-23 | S | D | 46,614 | $28.21 | 202,219 | D | — | — | (F3) This is the weighted average sales price representing 46,614 shares sold at prices ranging from $27.95 to $28.45 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 7 | Derivative | Stock Option (right to buy) | 2021-12-23 | M | D | 3,386 | $0.00 | 0 | D | $3.40 · — to 2022-09-10 | 3,386 Common Stock | (F5) The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. |
| 8 | Derivative | Stock Option (right to buy) | 2021-12-27 | M | D | 46,614 | $0.00 | 30,228 | D | $14.24 · — to 2022-10-31 | 46,614 Common Stock | (F5) The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. |
| 9 | Derivative | Stock Option (right to buy) | 2021-12-23 | M | D | 46,614 | $0.00 | 76,842 | D | $14.24 · — to 2022-10-31 | 46,614 Common Stock | (F5) The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. |